CoChat

Small molecule PROTACs in targeted therapy: An emerging strategy to induce protein degradation

Open access
Xi, Meiyang, Chen, Yi, Yang, Hongyu, Xu, Huiting, Du, Kui, Wu, Chunlei, Xu, Yanfei, Deng, Liping, Luo, Xiang, Yu, Lemao, Wu, Yonghua, Gao, Xiaozhong, Cai, Tao, Chen, Bin, Shen, Runpu, Sun, Haopeng · 2019 · European Journal of Medicinal Chemistry
Cited by 54

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Abstract

Inhibitors and nucleic acid based techniques were two main approaches to interfere with protein signaling and respective cascade in the past. Until recently, a new class of small molecules named proteolysis-targeting chimeras (PROTACs) have emerged. Each contains a target warhead, a linker and an E3 ligand. These bifunctional molecules recruit E3 ligases and target specific proteins for degradation via the ubiquitin (Ub) proteasome system (UPS). The degradation provides several advantages over inhibition in potency, selectivity and drug resistance. Thus, a variety of small molecule PROTACs have been discovered so far. In this review, we summarize the biological mechanism, advantages and recent progress of PROTACs, trying to offer an outlook in development of drugs targeting degradation in future.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ejmech.2019.04.036

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 49 references

Cited by

See all 54

Metadata

Authors
Xi, M., Chen, Y., Yang, H., Xu, H., Du, K., Wu, C., Xu, Y., Deng, L., Luo, X., Yu, L., Wu, Y., Gao, X., Cai, T., Chen, B., Shen, R., & Sun, H.
Venue
European Journal of Medicinal Chemistry
Publisher
Elsevier BV
Published
2019-07
Volume
174
Pages
159-180
ISSN
0223-5234 (ISSN-L)
OpenAlex
W2938819274
Cited by
54
References
49
FWCI
2.29
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Small molecule PROTACs in targeted therapy: An emerging strategy to induce protein degradation. https://app.cochat.ai/papers/10.1016/j.ejmech.2019.04.036
The paper
Xi, M., Chen, Y., Yang, H., Xu, H., Du, K., Wu, C., Xu, Y., Deng, L., Luo, X., Yu, L., Wu, Y., Gao, X., Cai, T., Chen, B., Shen, R., & Sun, H. (2019). Small molecule PROTACs in targeted therapy: An emerging strategy to induce protein degradation. European Journal of Medicinal Chemistry. https://doi.org/10.1016/j.ejmech.2019.04.036

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.